{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:20:32Z","timestamp":1791505232109,"version":"4.3.4"},"reference-count":46,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,8,10]]},"DOI":"10.1253\/circrep.cr-26-0151","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:09:45Z","timestamp":1782166185000},"page":"1299-1307","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Utility of Regional Longitudinal Strain in Patients With Immunoglobulin Light-Chain Cardiac Amyloidosis\u3000\u2015 A Report From the J-CASE Multicenter Survey \u2015"],"prefix":"10.1253","volume":"8","author":[{"given":"Hiroki","family":"Usuku","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Kumamoto University Hospital"},{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Oike","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kuyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hoshiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kanazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kitada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ohte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study. <i>Ann Med<\/i> 2008; 40: 232\u2013239.","DOI":"10.1080\/07853890701842988"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitk\u00e4nen P. Frequency and distribution of senile cardiovascular amyloid: A clinicopathologic correlation. <i>Am J Med<\/i> 1983; 75: 618\u2013623.","DOI":"10.1016\/0002-9343(83)90443-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Minamisawa M, Konishi H, Kitano Y, Abe H, Togo K, Izumiya Y. Patient journey to transthyretin cardiac amyloidosis diagnosis: A Japanese Claims Database Study. <i>Circ J<\/i> 2025; 89: 432\u2013441.","DOI":"10.1253\/circj.CJ-24-0666"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Palladini G, Milani P, Merlini G. Management of AL amyloidosis in 2020. <i>Blood<\/i> 2020; 136: 2620\u20132627.","DOI":"10.1182\/blood.2020006913"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kyle RA, Greipp PR, O\u2019Fallon WM. Primary systemic amyloidosis: Multivariate analysis for prognostic factors in 168 cases. <i>Blood<\/i> 1986; 68: 220\u2013224.","DOI":"10.1182\/blood.V68.1.220.bloodjournal681220"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Milani P, Merlini G, Palladini G. Light chain amyloidosis. <i>Mediterr J Hematol Infect Dis<\/i> 2018; 10: e2018022.","DOI":"10.4084\/mjhid.2018.022"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gillmore JD, Wechalekar A, Bird J, Cavenagh J, Hawkins S, Kazmi M, et al. Guidelines on the diagnosis and investigation of AL amyloidosis. <i>Br J Haematol<\/i> 2015; 168: 207\u2013218.","DOI":"10.1111\/bjh.13156"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. <i>Circ Res<\/i> 2004; 94: 1008\u20131010.","DOI":"10.1161\/01.RES.0000126569.75419.74"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, et al. Echocardiographic findings in systemic amyloidosis: Spectrum of cardiac involvement and relation to survival. <i>J Am Coll Cardiol<\/i> 1985; 6: 737\u2013743.","DOI":"10.1016\/S0735-1097(85)80475-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kristen AV, Perz JB, Schonland SO, Hegenbart U, Schnabel PA, Kristen JH, et al. Non-invasive predictors of survival in cardiac amyloidosis. <i>Eur J Heart Fail<\/i> 2007; 9: 617\u2013624.","DOI":"10.1016\/j.ejheart.2007.01.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al. Cardiac amyloidosis: Updates in diagnosis and management. <i>Arch Cardiovasc Dis<\/i> 2013; 106: 528\u2013540.","DOI":"10.1016\/j.acvd.2013.06.051"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using 2-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. <i>Heart<\/i> 2012; 98: 1442\u20131448.","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liu D, Hu K, Niemann M, Herrmann S, Cikes M, Stork S, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 1066\u20131072.","DOI":"10.1161\/CIRCIMAGING.113.000683"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: Validation against sonomicrometry and tagged magnetic resonance imaging. <i>J Am Coll Cardiol<\/i> 2006; 47: 789\u2013793.","DOI":"10.1016\/j.jacc.2005.10.040"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: Incremental value compared with clinical and biochemical markers. <i>J Am Coll Cardiol<\/i> 2012; 60: 1067\u20131076.","DOI":"10.1016\/j.jacc.2012.04.043"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, et al. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. <i>Eur Heart J Cardiovasc Imaging<\/i> 2017; 18: 1057\u20131064.","DOI":"10.1093\/ehjci\/jew298"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, et al. Prognosis of light chain amyloidosis with preserved LVEF: Added value of 2D speckle-tracking echocardiography to the current prognostic staging system. <i>JACC Cardiovasc Imaging<\/i> 2017; 10: 398\u2013407.","DOI":"10.1016\/j.jcmg.2016.04.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Usuku H, Yamamoto E, Sueta D, Noguchi M, Fujisaki T, Egashira K, et al. Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis. <i>Eur Heart J Open<\/i> 2023; 3: oead048.","DOI":"10.1093\/ehjopen\/oead048"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kitada S, Kawada Y, Shintani Y, Yamamoto J, Kikuchi S, Usuku H, et al. Echocardiographic features of wild-type transthyretin cardiac amyloidosis from J-Case: Multicenter survey in Japan. <i>JACC Asia<\/i> 2025; 5: 633\u2013646.","DOI":"10.1016\/j.jacasi.2025.01.016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 Guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. <i>J Am Soc Echocardiogr<\/i> 2010; 23: 685\u2013713; quiz 86\u201388.","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr<\/i> 2015; 28: 1\u201339.e14.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr<\/i> 2016; 29: 277\u2013314.","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Adler Y, Charron P, Imazio M, Badano L, Bar\u00f3n-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2015; 36: 2921\u20132964.","DOI":"10.5603\/KP.2015.0228"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. <i>J Am Soc Echocardiogr<\/i> 2017; 30: 303\u2013371.","DOI":"10.1016\/j.echo.2017.01.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using 2-dimensional speckle tracking echocardiography: A consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. <i>Eur Heart J Cardiovasc Imaging<\/i> 2018; 19: 591\u2013600.","DOI":"10.1093\/ehjci\/jey042"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hashimoto T, Ikuta K, Yamamoto S, Yoshitake T, Suenaga T, Nakashima S, et al. Right ventricular to pulmonary artery uncoupling is associated with impaired exercise capacity in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2024; 89: 31\u201340.","DOI":"10.1253\/circj.CJ-24-0402"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Arima N, Ochi Y, Kubo T, Murakami Y, Nishino K, Yamamoto H, et al. Prospective multicenter screening with high-sensitivity cardiac troponin T for wild-type transthyretin cardiac amyloidosis in outpatient and community-based settings. <i>Circ J<\/i> 2024; 89: 24\u201330.","DOI":"10.1253\/circj.CJ-24-0479"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Usuku H, Yamamoto E, Imamura K, Higashi R, Nozuhara A, Oike F, et al. Usefulness of regional longitudinal strain to identify transthyretin amyloid cardiomyopathy. <i>Circ Rep<\/i> 2026; 8: 495\u2013497.","DOI":"10.1253\/circrep.CR-25-0269"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yamasaki H, Kondo H, Shiroo T, Iwata N, Masuda T, Makita T, et al. Efficacy of computed tomography-based evaluation of myocardial extracellular volume combined with red flags for early screening of concealed cardiac amyloidosis in patients with atrial fibrillation. <i>Circ J<\/i> 2024; 88: 1167\u20131175.","DOI":"10.1253\/circj.CJ-23-0948"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Janwanishstaporn S, Cho JY, Feng S, Brann A, Seo JS, Narezkina A, et al. Prognostic value of global longitudinal strain in patients with heart failure with improved ejection fraction. <i>JACC Heart Fail<\/i> 2022; 10: 27\u201337.","DOI":"10.1016\/j.jchf.2021.08.007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Spinelli L, Bianco A, Riccio E, Pisani A, Iaccarino G. Cardiac involvement in Anderson-Fabry disease. The role of advanced echocardiography. <i>Front Cardiovasc Med<\/i> 2024; 11: 1440636.","DOI":"10.3389\/fcvm.2024.1440636"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takeda Y. Predicting low global longitudinal strain in patients with preclinical heart failure. <i>Circ J<\/i> 2024; 88: 711\u2013712.","DOI":"10.1253\/circj.CJ-24-0159"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nojiri A, Morimoto S, Fukuro E, Okuyama T, Anan I, Kawai M, et al. Role of longitudinal strain in the evaluation of contractile dysfunction in Japanese Fabry disease patients. <i>Circ J<\/i> 2024; 89: 53\u201361.","DOI":"10.1253\/circj.CJ-24-0509"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH. Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. <i>JACC Cardiovasc Imaging<\/i> 2010; 3: 121\u2013131.","DOI":"10.1016\/j.jcmg.2009.09.025"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Robin G, Cognet T, Bouisset F, Cariou E, M\u00e9jean S, Pradel S, et al. Value of longitudinal strain to identify wild-type transthyretin amyloidosis in patients with aortic stenosis. <i>Circ J<\/i> 2021; 85: 1494\u20131504.","DOI":"10.1253\/circj.CJ-20-1064"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Usuku H, Takashio S, Yamamoto E, Kinoshita Y, Nishi M, Oike F, et al. Usefulness of relative apical longitudinal strain index to predict positive (99 m) Tc-labeled pyrophosphate scintigraphy findings in advanced-age patients with suspected transthyretin amyloid cardiomyopathy. <i>Echocardiography<\/i> 2020; 37: 1774\u20131783.","DOI":"10.1111\/echo.14892"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Lee CY, Nabeshima Y, Kitano T, Yang LT, Takeuchi M. Diagnostic accuracy and prognostic value of relative apical sparing in cardiac amyloidosis: Systematic review and meta-analysis. <i>Circ J<\/i> 2024; 89: 16\u201323.","DOI":"10.1253\/circj.CJ-24-0472"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. <i>JACC Cardiovasc Imaging<\/i> 2018; 11: 234\u2013242.","DOI":"10.1016\/j.jcmg.2017.06.020"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. De Gaspari M, Sinigiani G, De Michieli L, Della Barbera M, Rizzo S, Thiene G, et al. Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient. <i>Eur Heart J Cardiovasc Imaging<\/i> 2023; 24: 1258\u20131268.","DOI":"10.1093\/ehjci\/jead107"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Senapati A, Sperry BW, Grodin JL, Kusunose K, Thavendiranathan P, Jaber W, et al. Prognostic implication of relative regional strain ratio in cardiac amyloidosis. <i>Heart<\/i> 2016; 102: 748\u2013754.","DOI":"10.1136\/heartjnl-2015-308657"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. <i>JACC Cardiovasc Imaging<\/i> 2010; 3: 333\u2013342.","DOI":"10.1016\/j.jcmg.2009.11.013"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Liu D, Hu K, Niemann M, Herrmann S, Cikes M, St\u00f6rk S, et al. Impact of regional left ventricular function on outcome for patients with AL amyloidosis. <i>PLoS One<\/i> 2013; 8: e56923.","DOI":"10.1371\/journal.pone.0056923"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Usuku H, Yamamoto E, Sueta D, Noguchi M, Fujisaki T, Egashira K, et al. Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy. <i>Int J Cardiol Heart Vasc<\/i> 2022; 43: 101146.","DOI":"10.1016\/j.ijcha.2022.101146"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Palladini G, Sachchithanantham S, Milani P, Gillmore J, Foli A, Lachmann H, et al. A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis. <i>Blood<\/i> 2015; 126: 612\u2013615.","DOI":"10.1182\/blood-2015-01-620302"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. <i>N Engl J Med<\/i> 2021; 385: 46\u201358.","DOI":"10.1056\/NEJMoa2028631"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/8\/8_CR-26-0151\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:29:44Z","timestamp":1786764584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/8\/8_CR-26-0151\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0151","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"CR-26-0151"}}